Stephen Ubl, president and CEO of the Advanced Medical Technology Association, discusses the potential impact of new payment models, as well as regulatory and tax issues, on the $110 billion device industry. He spoke with Modern Healthcare reporter Sabriya Rice.
AdvaMed CEO Stephen Ubl on new payment models, repealing device tax
Ubl
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content